CSIMarket


Alkermes Plc   (ALKS)
Other Ticker:  
 

Alkermes Plc

ALKS's Fundamental analysis








Looking into Alkermes Plc growth rates, revenue grew by 50.95 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 353

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.74 %

Alkermes Plc realized net income compared to net loss a year ago in III. Quarter 2023

More on ALKS's Growth


Alkermes Plc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Alkermes Plc PEG ratio is at -0.1 Company is currently trading with Price to Cash flow multiple of 14.42 in trailing twelve-month period.
Company
25.95
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.48.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.38.


More on ALKS's Valuation
 
 Total Debt (Millions $) 291
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 636,242
 Net Income/Employee (TTM) $ 85,890
 Receivable Turnover (TTM) 5.18
 Tangible Book Value (Per Share $) 7.28

Alkermes Plc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Alkermes Plc PEG ratio is at -0.1 Company is currently trading with Price to Cash flow multiple of 14.42 in trailing twelve-month period.
Company
25.95
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.48.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.38.

Alkermes Plc Price to Book Ratio is at 4.08 lower than Indusry Avg. of 1201.12. and higher than S&P 500 Avg. of -2105.95

More on ALKS's Valuation

  Market Capitalization (Millions $) 5,532
  Shares Outstanding (Millions) 172
  Employees 2,500
  Revenues (TTM) (Millions $) 1,591
  Net Income (TTM) (Millions $) 215
  Cash Flow (TTM) (Millions $) 384
  Capital Exp. (TTM) (Millions $) -41
  Total Debt (Millions $) 291
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 636,242
  Net Income/Employee(TTM) $ 85,890
  Receivable Turnover Ratio (TTM) 5.18
  Tangible Book Value (Per Share $) 7.28

  Market Capitalization (Millions $) 5,532
  Shares Outstanding (Millions) 172
  Employees 2,500
  Revenues (TTM) (Millions $) 1,591
  Net Income (TTM) (Millions $) 215
  Cash Flow (TTM) (Millions $) 384
  Capital Exp. (TTM) (Millions $) -41


    ALKS's Profitability Comparisons
Alkermes Plc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2023 to 11.51 % from 38.74 % in II. Quarter.

Alkermes Plc net profit margin of 12.54 % is currently ranking no. 44 in Major Pharmaceutical Preparations industry, ranking no. 93 in Healthcare sector and number 1154 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 2.91
  Total Debt to Equity (MRQ) 0.21
  Tangible Leverage Ratio (MRQ) 0.68
  Asset Turnover Ratio (TTM) 0.8
  Inventory Turnover Ratio (TTM) 1.27



Alkermes Plc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2023 to 11.51 % from 38.74 % in II. Quarter.

Alkermes Plc net profit margin of 12.54 % is currently ranking no. 44 in Major Pharmaceutical Preparations industry, ranking no. 93 in Healthcare sector and number 1154 in S&P 500.

More on ALKS's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com